Brainstorm Cell Therapeutics
Why Robinhood?
You can watch BCLI and buy or sell other stocks, ETFs, and their options commission-free!About BCLI
Brainstorm Cell Therapeutics, Inc. is a biotechnology company, which develops and commercializes autologous cellular therapies for the treatment of neurodegenerative diseases, including Amyotrophic Lateral Sclerosis, Progressive Multiple Sclerosis, Alzheimer's disease, and other neurodegenerative diseases. Its pipeline, NurOwn proprietary cell therapy platform, leverages cell culture methods to induce autologous bone marrow-derived mesenchymal stem cells to secrete high levels of neurotrophic factors, modulate neuroinflammatory and neurodegenerative disease processes, promote neuronal survival, and improve neurological function.
BCLI Key Statistics
Stock Snapshot
With a market cap of 66.28M, Brainstorm Cell Therapeutics(BCLI) trades at $0.82. The stock has a price-to-earnings ratio of -15.25.
On 2026-10-24, Brainstorm Cell Therapeutics(BCLI) stock traded between a low of $0.75 and a high of $0.83. Shares are currently priced at $0.82, which is +9.2% above the low and -1.4% below the high.
Brainstorm Cell Therapeutics(BCLI) shares are trading with a volume of 19.19K, against a daily average of 385.89K.
In the last year, Brainstorm Cell Therapeutics(BCLI) shares hit a 52-week high of $0.83 and a 52-week low of $0.13.
In the last year, Brainstorm Cell Therapeutics(BCLI) shares hit a 52-week high of $0.83 and a 52-week low of $0.13.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.